This year’s Biologic Association Summit (BAS) program focused on optimizing patient outcomes by preparing patients’ lifestyles, developing the ideal platelet rich plasma (PRP) preparation, understanding the latest research, and comparing experiences related to the best treatment procedures for specific anatomical areas and indications. This theme also influenced the orthobiologics presentations on the agenda at the Arthroscopy Association of North America (AANA25) meeting recently held in Washington, DC. Additional topics included recent updates in the regulatory landscape and their potential impact on clinical practice and industry partners that manufacture orthobiologic products. This article will provide a brief overview of the key takeaways from both meetings and the possible implications for the Orthobiologic and Regenerative Medicine Markets.
Among the many topics covered in this downloadable article are:
Overall, the two meetings provided an impressive lineup of experts in the field who delivered detailed presentations and engaged in informative panel discussions on the latest research and opinions regarding breakthrough therapies and practical applications of biologic treatments in orthopedics.
Click below to download the full article, “BA Summit and AANA Join Forces to Share Orthobiologic Insights” co-authored by David Shepard, SmartTRAK GM/Sr Analyst, Orthobio & Regen and Emily Meng, SmartTRAK Analyst, Orthobiologics.